pharmaceutical stocks – SRK Analytics

A stunning aerial view of Indianapolis downtown skyline during sunset, capturing the vibrant cityscape.

Eli Lilly vs Novo Nordisk: Analyzing the Top Pharmaceutical Stocks

Compare pharmaceutical giants Eli Lilly and Novo Nordisk in this expert analysis. Discover which healthcare stock presents the best investment opportunity.

Prasenjit Bhowmik November 8, 2026

Person wearing black glove grabbing a vaccine vial against a bright red backdrop.

Market

Eli Lilly and the Massive Incretin Market Opportunity

Explore Eli Lilly's massive presence in the incretin market and analyze whether future stock growth and upside potential remain strong.

Prasenjit Bhowmik November 1, 2026

Wooden tiles spelling ETF growth on a wooden surface, symbolizing investment strategy.

Emerging Market

Eli Lilly Investment Forecast: Growth Potential Over Five Years

Explore the potential growth of a 5000 dollar investment in Eli Lilly stock over a five-year horizon based on market trends and pharmaceutical demand.

Prasenjit Bhowmik October 25, 2026

Flat lay of pill blister packs on a red and blue surface, ideal for healthcare themes.

Emerging Market

Fosun Pharma Sells 6 Percent Stake in Gland Pharma for 2800 Crore Rupees

Fosun Pharma divests a 6 percent stake in Gland Pharma via a block deal worth 2800 crore rupees, lowering its total shareholding to 45.77 percent.

Prasenjit Bhowmik October 7, 2026

Pink tablets in a blister pack, emphasizing healthcare and medication concepts.

Emerging Market

Gland Pharma Shares in Focus as Promoter Fosun Plans Major Stake Sale

Gland Pharma shares draw market attention as promoter Fosun initiates a block deal to divest a five percent equity stake worth over two thousand crores.

Prasenjit Bhowmik September 25, 2026